XML 48 R29.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Compensation Expense and Shareholders' Equity (Tables)
 9 Months Ended
Apr. 30, 2022
Stockholders' Equity and Stock-based Compensation [Abstract]  
Stock-based compensation expense Stock-based compensation expense related to stock options and Stock Awards is included in the Company’s condensed consolidated statements of operations as follows (in thousands):
Three Months Ended April 30,Nine Months Ended April 30,
2022202120222021
Stock-based compensation expense$33,241 $28,568 $103,921 $87,171 
Net impact of deferred stock-based compensation(313)(345)(888)(968)
 Total stock-based compensation expense, net$32,928 $28,223 $103,033 $86,203 
Stock-based compensation expense is included in the following categories:
Cost of subscription and support revenue$4,051 $2,780 $11,172 $8,336 
Cost of license revenue170 183 541 579 
Cost of services revenue5,879 5,395 17,597 16,516 
Research and development9,293 6,930 27,340 21,781 
Sales and marketing7,529 6,587 25,843 19,370 
General and administrative6,006 6,348 20,540 19,621 
Total stock-based compensation expense$32,928 $28,223 $103,033 $86,203 
Schedule of Share-based Compensation, Restricted Stock Units Award Activity
A summary of Stock Awards activity under the Company’s equity incentive plans is as follows:
 Stock Awards Outstanding
 Number of Stock Awards Outstanding Weighted Average Grant Date Fair Value
 Aggregate Intrinsic Value (in thousands)(1)
Balance as of July 31, 20212,394,968 $107.15 $275,900 
Granted1,808,883 $115.79 
Released(934,183)$106.42 $99,582 
Canceled(285,715)$111.36 
Balance as of April 30, 20222,983,953 $112.21 $259,425 
Expected to vest as of April 30, 20222,983,953 $112.21 $259,425 
(1) Aggregate intrinsic value at each period end represents the total market value of Stock Awards at the Company’s closing stock price of $86.94 and $115.20 on April 30, 2022 and July 31, 2021, respectively. Aggregate intrinsic value for released Stock Awards represents the total market value of released Stock Awards at date of release.
Schedule of Share-based Compensation, Stock Options, Activity A summary of stock option activity under the Company’s equity incentive plans is as follows:
 Stock Options Outstanding
 Number of Stock Options Outstanding Weighted Average Exercise PriceWeighted Average Remaining Contractual Life
 Aggregate Intrinsic Value(1)
(in years) (in thousands)
Balance as of July 31, 202125,278 $17.39 5.0$2,472 
Granted— 
Exercised(10,432)$11.10 $1,044 
Canceled— 
Balance as of April 30, 202214,846 $21.82 3.8$967 
Vested and expected to vest as of April 30, 202214,846 $21.82 3.8$967 
Exercisable as of April 30, 202214,846 $21.82 3.8$967 
(1) Aggregate intrinsic value at each period end represents the difference between the Company’s closing stock price of $86.94 and $115.20 on April 30, 2022 and July 31, 2021, respectively, and the exercise price of outstanding options. Aggregate intrinsic value for exercised options represents the difference between the Company’s stock price at date of exercise and the exercise price.
Common Stock Reserved for Issuance
As of April 30, 2022 and July 31, 2021, the Company had reserved shares of common stock for future issuance as follows:
April 30, 2022July 31, 2021
Exercise of stock options to purchase common stock14,846 25,278 
Vesting of stock awards2,983,953 2,394,968 
Shares available under stock plans3,490,901 5,014,069 
Total common stock reserved for issuance6,489,700 7,434,315